The insider sales are immaterial relative to market cap and likely driven by routine diversification or tax planning. The CEO's gift and director's gift are non-cash events with no market signal. Monitor upcoming earnings for any fundamental changes, but this cluster alone does not warrant a bearish read.
CORT drugs
CORT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 1 $70.44entry
- T+1 · 6mo ago +1.08%α +0.93% · $71.20
- T+5 · 5mo ago +3.09%α +5.84% · $72.62
- T+20 · 5mo ago +23.44%α +24.74% · $86.95
- T+60 · 3mo ago +75.43%α +74.19% · $123.57
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Corcept Therapeutics insiders sold a combined $3.89M in open-market sales on May 27, 2026, with CEO Belanoff also gifting 300,000 shares (non-cash) on May 29. The sales represent ~0.05% of the $7.6B market cap, well below the 0.1% materiality threshold, and are likely routine liquidity/vesting-related transactions rather than a bearish signal.
Key Financial Metrics
Key Facts
- Maduck Sean sold 54,575 shares at $65.37 for $3.57M on May 27
- Lyon Joseph Douglas sold 5,000 shares at $65.00 for $325K on May 27
- CEO Belanoff gifted 300,000 shares at $0 (non-cash) on May 29
- CEO Belanoff also sold 12,837 shares at $69.74 for $895K on June 1
- Total open-market sales in cluster: $3.89M, or ~0.05% of $7.6B market cap
- Director Wilson gifted 892,056 shares at $0 (non-cash) on May 27
- Maduck also exercised 75,000 derivative shares at $8.27 for $620,250 (non-cash exercise)
Financial Impact
Open-market sales of $3.89M represent ~0.05% of market cap, trivial relative to company size
Risk Factors
- CEO's June 1 sale at higher price ($69.74) could indicate incremental selling, but still small relative to his holdings
- No insider buying to offset the selling pattern
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1780430796567 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers